Technical / White Paper
Age-defining Eye Saviors: A new clinical study of XanMax®
A randomized, double blind, placebo controlled, parallel study has been recently conducted for a duration of 180 days in elderly volunteers.
Statistically significant results demonstrated that XanMax® supports healthy macula through deposition of optimal levels of carotenoid pigments.
Furthermore, the study also demonstrated that the formulation was safe and well tolerated when administrated orally.
XanMax® is an innovative formulation of Zeaxanthin in combination with Lutein which is available from natural Marigold flowers.
XanMax® is part of the Gee Lawson range of speciality ingredients, exclusively distributed in all Europe by LEHVOSS Group.
